InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,462.80
(
0.25%
)
Dow Jones
38,675.68
(
0.00%
)
Brent Oil
83.54
(
0.49%
)
Bitcoin
64,119.09
(
0.19%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: north40000 post# 33991

Friday, 09/23/2011 2:04:17 PM

Friday, September 23, 2011 2:04:17 PM

Post# of 92948
north,


Advanced Cell Technology, Inc. (OTCBB: ACTC) announced today that it has reached a supply agreement with Biologics Delivery Systems Group, Cordis Corporation (a Johnson & Johnson company), in which Biologics Delivery Systems will supply catheters for the Phase II human clinical trial of ACT’s myoblast therapy for the treatment of heart failure
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=34729427
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up